首页 > 市场调查报告书 > 製药

个人化医学

市场调查报告书

商品编码

1274332

个性化医疗生物标誌物的全球市场研究报告——2023-2030 年行业分析、规模、份额、增长、趋势和预测

Global Personalized Medicine Biomarkers Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年05月01日 | 出版商:

Value Market Research | 英文 125 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球对个性化医疗生物标誌物市场的需求将从2022年的249.2亿美元增长到2030年的近1754.6亿美元，2023-2030年研究期间复合年增长率为27.63%，预计将达到市场规模。

个性化药物生物标誌物是利用生物标誌物为患者开发个性化药物。它支持治疗政策决策、治疗结果的改善以及为患□□者建立安全的治疗方法。它也是预后性的，因此可用于预测健康问题的发生和选择剂量。生物标誌物可以帮助更早发现疾病、提高患者生存率并降低治疗成本。

市场动态：

由于全球慢性病患病率上升，个性化医疗生物标誌物市场正在蓬勃发展。诊断和检测慢性病的进步以及对个性化医疗的需求不断增加，都促进了这一市场的增长。人们越来越意识到预后预测的重要性，这推动了对个性化医学生物标誌物市场的需求。此外，个性化医学生物标誌物的各种优势，如早期发现疾病和降低治疗成本，正在推动这一市场的需求。此外，生物标誌物开发的持续进展有望在预测期内推动个性化医疗生物标誌物的市场增长。

这份研究报告解释了波特的五力模型、市场吸引力分析和价值链分析。这些工具可帮助您清楚地了解您的行业结构并评估您在全球范围内的竞争吸引力。此外，这些工具还对全球个性化医疗生物标誌物市场的各个细分市场进行全面评估。个性化医疗生物标誌物行业的发展和趋势为这项研究提供了一种整体方法。

市场细分：

在本节中，我们将按国家和地区提供详细的细分数据，确定产品和服务的目标受众，并支持未来的商机。

使用

早期检测/筛查
诊断
治疗选择
监控

根据指示

肿瘤学（类型、循环生物标誌物）
神经学
糖尿病
自身免疫性疾病
循环区
其他

按地区分析：

本部分涵盖区域展望，重点介绍北美、欧洲、亚太地区、拉丁美洲、中东和非洲对个性化医疗生物标誌物市场的当前和未来需求。此外，我们还关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的综合概况和全球竞争格局的详细视图。个性化医学生物标誌物市场的主要参与者是美国控股实验室公司、Quest Diagnostics Incorporated、Agilent Technologies Inc、Genome Medical Inc、Coriell Life Sciences.、Thermo Fisher Scientific Inc.、NeoGenomics Laboratories、Foundation Medicine Inc、Illumina Inc、Guardant Health . 本节概述了竞争格局，包括各种战略发展，例如主要併购、未来能力、合作伙伴关係、财务概览、合作、新产品开发和新产品发布。

内容

第一章前言

本报告的内容
- 目的
- 目标受众
- 独特的销售主张 (USP) 及其提供的内容
调查范围
调查方法
- 市场调研过程
- 市场研究方法

第 2 章执行摘要

市场亮点
全球市场概况

第 3 章个性化医疗生物标誌物 - 行业分析

简介 - 市场动态
市场驱动力
市场製约因素
商机
行业趋势
波特的五力分析
市场吸引力分析
- 市场吸引力分析：按应用
- 按市场进行的吸引力分析：按指示
- 市场吸引力分析：按地区

第四章价值链分析

价值链分析
原材料分析
- 原材料清单
- 原材料製造商列表
- 主要原材料价格走势
潜在买家名单
营销渠道
- 直接营销
- 间接营销
- 营销渠道趋势

第 5 章 COVID-19 爆发的影响分析

第 6 章个性化医疗生物标誌物的全球市场分析：按应用

总结：按应用
实际数据和预测数据
分析：按应用
早期检测/筛查
诊断
治疗选择
监控

第 7 章个性化医疗生物标誌物的全球市场分析：按适应症分类

适应症概览
历史和预测数据
适应症分析
肿瘤学（类型、循环生物标誌物）
神经学
糖尿病
自身免疫性疾病
循环区
其他

第 8 章个性化医疗生物标誌物的全球市场分析：按地区

区域展望
简介
北美销售分析
- 概览、历史和预测销售分析
- 北美各部门的销售分析
- 北美销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史和预测销售分析
- 按细分市场进行的欧洲销售分析
- 按国家/地区划分的欧洲销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 意大利销售分析
- 俄罗斯销售分析
- 其他欧洲销售分析
亚太地区销售分析
- 概览、历史和未来销售分析
- 亚太地区各部门的销售分析
- 亚太国家/地区销售分析
- 在中国的销售分析
- 印度销售分析
- 日本的销售分析
- 韩国销售分析
- 澳大利亚销售分析
- 其他亚太地区销售分析
拉丁美洲销售分析
- 概览、历史和未来销售分析
- 拉丁美洲各部门的销售分析
- 拉丁美洲国家/地区的销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利的销售分析
- 其他拉丁美洲销售分析
中东和非洲销售分析
- 概览、历史和未来销售分析
- 中东/非洲地区的销售分析
- 中东和非洲国家/地区的销售分析
- 沙特阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 其他中东和非洲销售分析

第9章个性化医疗生物标誌物公司的竞争状况

个性化医疗生物标誌物市场竞争
伙伴关係、合作、协议
併购
新产品发布
其他发展

第十章公司简介

顶级公司的市场份额分析
市场集中度
美国控股实验室公司
- 公司简介
- 企业收入
- 产品介绍
- 近期发展状况
奎斯特诊断公司
- 公司简介
- 企业收入
- 产品信息
- 近期发展状况
安捷伦科技公司
- 公司简介
- 企业收入
- 产品信息
- 近期发展状况
基因组医疗公司
- 公司简介
- 企业收入
- 产品信息
- 近期发展状况
Coriell 生命科学。
- 公司简介
- 企业收入
- 产品信息
- 近期发展状况
Thermo Fisher Scientific Inc.
- 公司简介
- 企业收入
- 产品信息
- 近期发展状况
新基因组学实验室
- 公司简介
- 企业收入
- 产品信息
- 近期发展状况
Foundation Medicine Inc.
- 公司简介
- 企业收入
- 产品信息
- 近期发展状况
因美纳公司
- 公司简介
- 企业收入
- 产品信息
- 近期发展状况
守护健康
- 公司简介
- 企业收入
- 产品信息
- 近期趋势

注意：公司简介中的财务细节和近期发展基于可用信息，可能不包括私营公司。

简介目录图表

Product Code: VMR112110341

The global demand for Personalized Medicine Biomarkers Market is presumed to reach the market size of nearly USD 175.46 BN by 2030 from USD 24.92 BN in 2022 with a CAGR of 27.63% under the study period 2023 - 2030.

Personalised medicine biomarkers are the use of biomarkers for developing personalised medicines for patients. It assists in making treatment decisions, improving treatment outcomes and creating safe therapies for patients. It also helps predict the occurrence of health issues and dose selection due to their prognostic utility. Biomarker helps in the early detection of diseases, increase the chance of patient survival, and reduce treatment cost.

Market Dynamics:

The personalised medicine biomarkers market growth is witnessing an upward trend due to the rising prevalence of chronic diseases all over the globe. The advancement in diagnosis and detection of chronic diseases, coupled with the growing demand for personalised medicines, are contributing to the growth of this market. Increasing awareness regarding the importance of predicting prognosis is surging the demand for the personalised medicine biomarkers market. In addition, different advantages of personalised medicine biomarkers, such as early detection of diseases and reduction in the cost of treatment, are propelling the demand for this market. Furthermore, continuous advancement in the development of biomarkers is expected to boost the growth of personalised medicine biomarkers in the market over the forecast period.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of personalized medicine biomarkers. The growth and trends of personalized medicine biomarkers industry provide a holistic approach to this study.

Market Segmentation:

This section of the personalized medicine biomarkers market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Application

Early Detection/Screening
Diagnosis
Treatment Selection
Monitoring

By Indication

Oncology (Type, Circulating Biomarkers)
Neurology
Diabetes
Autoimmune Diseases
Cardiology
Others

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Personalized Medicine Biomarkers market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the personalized medicine biomarkers market include Laboratory Corporation of America Holding, Quest Diagnostics Incorporated, Agilent Technologies Inc., Genome Medical Inc., Coriell Life Sciences., Thermo Fisher Scientific Inc., NeoGenomics Laboratories, Foundation Medicine Inc, Illumina Inc., Guardant Health. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . PERSONALIZED MEDICINE BIOMARKERS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Application
- 3.7.2 Market Attractiveness Analysis By Indication
- 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET ANALYSIS BY APPLICATION

6.1 Overview by Application
6.2 Historical and Forecast Data
6.3 Analysis by Application
6.4 Early Detection/Screening Historic and Forecast Sales by Regions
6.5 Diagnosis Historic and Forecast Sales by Regions
6.6 Treatment Selection Historic and Forecast Sales by Regions
6.7 Monitoring Historic and Forecast Sales by Regions

7 . GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET ANALYSIS BY INDICATION

7.1 Overview by Indication
7.2 Historical and Forecast Data
7.3 Analysis by Indication
7.4 Oncology (Type, Circulating Biomarkers) Historic and Forecast Sales by Regions
7.5 Neurology Historic and Forecast Sales by Regions
7.6 Diabetes Historic and Forecast Sales by Regions
7.7 Autoimmune Diseases Historic and Forecast Sales by Regions
7.8 Cardiology Historic and Forecast Sales by Regions
7.9 Others Historic and Forecast Sales by Regions

8 . GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE PERSONALIZED MEDICINE BIOMARKERS COMPANIES

9.1. Personalized Medicine Biomarkers Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF PERSONALIZED MEDICINE BIOMARKERS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Laboratory Corporation of America Holding
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Quest Diagnostics Incorporated
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Agilent Technologies Inc.
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Genome Medical Inc.
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Coriell Life Sciences.
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Thermo Fisher Scientific Inc.
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. NeoGenomics Laboratories
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Foundation Medicine Inc
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Illumina Inc.
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. Guardant Health
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

简介目录图表